Melatonin as a medication and supplement

Source: Wikipedia, the free encyclopedia.
(Redirected from
Melatonin (supplement)
)
This article is about melatonin as a supplement and medication. For its role as a hormone, see Melatonin.

Melatonin
Clinical data
Pronunciation/ˌmɛləˈtoʊnɪn/ ⓘ
Trade namesCircadin, Slenyto, others[1]
Other namesN-Acetyl-5-methoxy tryptamine[2]
AHFS/Drugs.comConsumer Drug Information
License data
Pregnancy
category
Dependence
liability		Physical: Low[4] Psychological: Low
Physiological data
Source tissuesPineal gland
Target tissuesWidespread, including brain, retina, and circulatory system
ReceptorsMelatonin receptor
PrecursorN-Acetylserotonin
MetabolismLiver via CYP1A2 mediated 6-hydroxylation
Legal status
Legal status
  • AU: S4 (Prescription only)[3][5]
  • CA: OTC
  • UK: POM (Prescription only)
  • US: OTC
  • EU: Rx, OTC
  • In general: ℞ (Prescription only)
5-methoxytryptamine
Elimination half-lifeIR: 20–60 minutes[7][9][10]
PR: 3.5–4 hours[11][8]
ExcretionKidney
Identifiers
  • N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
JSmol)
Melting point117 °C (243 °F)
  • COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
  • InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16) checkY
  • Key:DRLFMBDRBRZALE-UHFFFAOYSA-N checkY
  (verify)

Melatonin is a

sleep–wake cycles.[9][12] As a supplement, it is often used for the attempted short-term treatment of disrupted sleep patterns, such as from jet lag or shift work, and is typically taken orally.[13][14][15] Evidence of its benefit for this use, however, is not strong.[16] A 2017 review found that sleep onset occurred six minutes faster with use, but found no change in total time asleep.[14]

Side effects from melatonin supplements are minimal at low doses for short durations (in the studies reported about equally for both melatonin and placebo).

hungover.[8][18][17][19][20] Its use is not recommended during pregnancy or breastfeeding or for those with liver disease.[15][20]

Melatonin acts as an

elimination half-life of about 20 to 50 minutes.[22][9][10] Prolonged-release melatonin used as a medication has a half-life of 3.5 to 4 hours.[11][8]

Melatonin was discovered in 1958.

synthetic melatonin receptor agonists like ramelteon, tasimelteon, and agomelatine are also used in medicine.[24][25] In 2021, it was the 257th most commonly prescribed medication in the United States, with more than 1 million prescriptions.[26][27]

Medical uses

Insomnia

There is no good evidence that melatonin helps treat insomnia and its attempted use for this purpose is recommended against by the American Academy of Sleep Medicine.[28]

A

prolonged-release form of melatonin is approved for use as a medication in Europe for the treatment of insomnia in certain people.[11][29]

Circadian rhythm sleep disorders

Melatonin may be useful in the treatment of delayed sleep phase syndrome.[9]

Melatonin is known to reduce jet lag, especially in eastward travel. However, if it is not taken at the correct time, it can instead delay adaptation.[30]

Melatonin appears to have limited use against the sleep problems of people who work shift work.[31] Tentative evidence suggests that it increases the length of time people are able to sleep.[31]

REM sleep behavior disorder

Melatonin is a safer alternative than

REM sleep behavior disorder – a condition associated with the synucleinopathies like Parkinson's disease and dementia with Lewy bodies.[32][33][34] However, clonazepam may be more effective.[35] In any case, the quality of evidence for both treatments is very low and it is unclear whether either is definitely effective.[35]

Dementia

A 2020

minimal cognitive impairment, after the onset of Alzheimer's disease it has little to no effect.[37] Melatonin may, however, help with sundowning (increased confusion and restlessness at night) in people with dementia.[38]

Available forms

A bottle of melatonin tablets. Melatonin is also available in timed-release and in liquid forms.

A

prolonged-release 2 mg oral formulation of melatonin sold under the brand name Circadin is approved for use in the European Union in the short-term treatment of insomnia in people age 55 and older.[11][29][8]

Melatonin is also available as an

over-the-counter dietary supplement in many countries. It is available in both immediate-release and less commonly prolonged-release forms. The compound is available in supplements at doses ranging from 0.3 mg to 10 mg or more. It is also possible to buy raw melatonin powder by the weight.[39] Immediate-release formulations of melatonin cause blood levels of melatonin to reach their peak in about an hour. The hormone may be administered orally, as capsules, gummies, tablets, or liquids. It is also available for use sublingually, or as transdermal patches.[40]

The American Academy of Sleep Medicine (AASM) said that the melatonin content in unregulated (without a USP verified mark) supplements can diverge widely from the claimed amount; a study found that the melatonin content ranged from one half to four times the stated dose.[41]

Contraindications

glucose–galactose malabsorption.[8] Use of melatonin is also not recommend in women who are pregnant or breastfeeding or in people with liver disease.[15][20]

Adverse effects

Melatonin appears to cause very few

side effects as tested in the short term, up to three months, at low doses.[clarification needed][dubious – discuss] Two systematic reviews found no adverse effects of exogenous melatonin in several clinical trials, and comparative trials found the adverse effects headaches, dizziness, nausea, and drowsiness were reported about equally for both melatonin and placebo.[42][43] Prolonged-release melatonin is safe with long-term use of up to 12 months.[11] Although not recommended for long-term use beyond this,[44] low-dose melatonin is generally safer, and a better alternative, than many prescription and over-the-counter sleep aids if a sleeping medication must be used for an extended period of time.[citation needed] Low doses of melatonin are usually sufficient to produce a hypnotic effect in most people. Higher doses do not appear to result in a stronger effect but instead appear to cause drowsiness for a longer period of time.[45]

There is emerging evidence that the timing of taking exogenous melatonin in relation to food is also an important factor.[46] Specifically, taking exogenous melatonin shortly after a meal is correlated with impaired glucose tolerance. Therefore, Rubio-Sastre and colleagues recommend waiting at least 2 hours after the last meal before taking a melatonin supplement.[47]

Melatonin can cause

immunomodulation.[49][50][needs update
]

Melatonin can lower follicle-stimulating hormone levels.[51] Melatonin's effects on human reproduction remain unclear.[52]

Some supplemental melatonin users report an increase in

REM sleep time and dream activity in people both with and without narcolepsy.[53]

Increased use of melatonin in the 21st century has significantly increased reports of melatonin overdose, calls to poison control centers, and related emergency department visits for children. The number of children who unintentionally ingested melatonin supplements in the US has increased 530% from 2012 to 2021. Over 4,000 reported ingestions required a hospital stay, and 287 children required intensive care. The American Academy of Sleep Medicine says there is little evidence that melatonin supplementation is effective in treating insomnia in healthy children.[41]

Overdose

Melatonin appears to be relatively safe in

drowsiness may be expected and the compound should be cleared within 12 hours.[8] No special treatment is needed for melatonin overdose.[8]

Interactions

Melatonin is

cigarette smoking, carbamazepine, and rifampicin may reduce melatonin exposure due to induction of CYP1A2.[8]

In those taking warfarin, some evidence suggests there may exist a potentiating interaction, increasing the anticoagulant effect of warfarin and the risk of bleeding.[54]

Pharmacology

Pharmacodynamics

Melatonin acts as an

endogenous melatonin.[21] Endogenous melatonin is normally secreted from the pineal gland of the brain.[21] Melatonin is thought to activate melatonin receptors in the suprachiasmatic nucleus of the hypothalamus to regulate the circadian clock and sleep–wake cycles.[21] When used several hours before sleep according to the phase response curve for melatonin in humans, small amounts (0.3 mg[55]) of melatonin shift the circadian clock earlier, thus promoting earlier sleep onset and morning awakening.[56]

Pharmacokinetics

Absorption

The

absorbed and distributed, reaching peak plasma concentrations after 60 minutes of administration, and is then eliminated.[6] Usual doses of exogenous melatonin of 1 to 12 mg produce melatonin concentrations 10 to 100 times higher than endogenous peak levels.[7]

Distribution

The

α1-acid glycoprotein, and high-density lipoprotein.[8]

The membrane transport proteins that move melatonin across a membrane include, but are not limited to, glucose transporters, including GLUT1, and the proton-driven oligopeptide transporters PEPT1 and PEPT2.[57][58]

Metabolism

Melatonin is

conjugated with sulfuric acid or glucuronic acid for excretion in the urine. Some of the metabolites formed via the reaction of melatonin with a free radical include cyclic 3-hydroxymelatonin, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK), and N1-acetyl-5-methoxykynuramine (AMK).[57][58]

Elimination

In humans, 90% of orally administered exogenous melatonin is cleared in a single passage through the liver, a small amount is excreted in urine, and a small amount is found in saliva.[13] Melatonin is excreted in the urine 2 to 5% as the unchanged drug.[6][8]

Melatonin has an

elimination half-life of about 20 to 60 minutes.[22][7][9][10] The half-life of prolonged-release melatonin (Circadin) is 3.5 to 4 hours.[11][8]

Chemistry

Melatonin, also known as N-acetyl-5-methoxytryptamine, is a

Synthetic melatonin receptor agonists used in medicine like ramelteon, tasimelteon, agomelatine, and piromelatine (still in clinical trials) are analogues
of melatonin.

History

The first

New England Journal of Medicine editorialized in 2000: "With these recent careful and precise observations in blind persons, the true potential of melatonin is becoming evident, and the importance of the timing of treatment is becoming clear."[62]

It was approved for medical use in the European Union in 2007.[8]

Society and culture

Melatonin is categorized by the US Food and Drug Administration (FDA) as a dietary supplement, and is sold over-the-counter in both the US and Canada.[13] FDA regulations applying to medications are not applicable to melatonin,[63] though the FDA has found false claims that it cures cancer.[64] As melatonin may cause harm in combination with certain medications or in the case of certain disorders, a doctor or pharmacist should be consulted before making a decision to take melatonin.[30] In many countries, melatonin is recognized as a neurohormone and it cannot be sold over-the-counter.[65] According to Harriet Hall caution is advisable, since quality control is a documented problem. 71% of products did not contain within 10% of the labelled amount of melatonin, with variations ranging from -83% to +478%, lot-to-lot variability was as high as 465%, and the discrepancies were not correlated to any manufacturer or product type. To make matters worse, 8 out of 31 products were contaminated with the neurotransmitter serotonin.[66][67]

Formerly, melatonin was derived from animal pineal tissue, such as bovine. It is now synthetic, which limits the risk of contamination or the means of transmitting infectious material.[63][68]

Melatonin is the most popular over-the-counter sleep remedy in the United States, resulting in sales in excess of US$400 million during 2017.[69] In 2021, it was the 257th most commonly prescribed medication in the US, with more than 1 million prescriptions.[26][27]

Beverages and snacks containing melatonin were being sold in grocery stores, convenience stores, and clubs in May 2011.[70] The FDA considered whether these food products could continue to be sold with the label "dietary supplements". On 13 January 2010, it issued a Warning Letter to Innovative Beverage, creators of several beverages marketed as drinks, stating that melatonin, while legal as a dietary supplement, was not approved as a food additive.[71] Bebida Beverage Company received a warning letter in 2015 for selling a melatonin-containing beverage.[72]

Research

Psychiatry

Depression

Some research supports an antidepressant effect of melatonin.[73]

Bipolar disorder

Melatonin, along with ramelteon, has been repurposed as a possible adjunctive treatment for manic episodes in bipolar disorder.[74] However, meta-analytic evidence is somehow inconsistent and of limited interest so far, although the small samples of trials do not allow ruling out its beneficial effect.[74] In any case, current evidence does not support the use of add-on melatonin-receptor agonists for mania.[74]

Anxiety

Melatonin in comparison to placebo is effective for reducing preoperative anxiety in adults when given as premedication. It may be just as effective as standard treatment with benzodiazepine in reducing preoperative anxiety. Melatonin may also reduce postoperative anxiety (measured 6 hours after surgery) when compared to placebo.[75]

Headaches

Tentative evidence shows melatonin may help reduce some types of headaches including cluster and hypnic headaches.[76][77]

Cancer

A 2013 review by the National Cancer Institute found insufficient evidence for melatonin having anti-cancer effects.[78] A 2022 review found that melatonin supplementation had a small improvement in survival of people with cancer at one year.[79][80] One review found that melatonin may alleviate chemotherapy-related side effects.[81]

Protection from radiation

Both animal

cellular membranes. Melatonin has been described as a broadly protective, readily available, and orally self-administered antioxidant that is without known, major side effects.[87]

Epilepsy

A 2016 review found no beneficial role of melatonin in reducing seizure frequency or improving quality of life in people with epilepsy.[88]

Dysmenorrhea

A 2016 review suggested no strong evidence of melatonin compared to placebo for dysmenorrhea secondary to endometriosis.[89]

Delirium

A 2016 review suggested no clear evidence of melatonin to reduce the incidence of delirium.[90]

Gastroesophageal reflux disease

A 2011 review said melatonin is effective in relieving

epigastric pain and heartburn.[91]

Tinnitus

A 2015 review of studies of melatonin in tinnitus found the quality of evidence low, but not entirely without promise.[92]

References

  1. ^ "Melatonin – Drugs.com". Drugs.com. Retrieved 12 October 2018.
  2. ^ "Melatonin". Sleepdex. Retrieved 17 August 2011.
  3. ^ a b https://www.tga.gov.au/resources/auspar/auspar-melatonin-1
  4. ^ a b c "Pros and cons of melatonin". Mayo Clinic. Retrieved 20 August 2022.
  5. ^ https://www.tga.gov.au/resources/auspar/auspar-melatonin-link-immela-melakso-voquily
  6. ^
    PMID 28503116
    .
  7. ^
    PMID 33540815
    .
  8. ^ a b c d e f g h i j k l m n o p q r s t u v w x y Circadin: EPAR - Product Information ANNEX I - SUMMARY OF PRODUCT CHARACTERISTICS (Report). European Medicines Agency (EMA). 2 February 2021. EMEA/H/C/000695 - IA/0066. As PDF. Archived 31 October 2022 at the Wayback Machine Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  9. ^
    PMID 28648359
    .
  10. ^
    S2CID 38857779
    .
  11. ^
    S2CID 1403262
    .
  12. ^
    ISBN 978-0-323-32602-5
    .
  13. ^
    PMID 15635761
    . Retrieved 5 June 2013.
  14. ^
    PMID 28671376
    .
  15. ^
    ISBN 978-0-85711-338-2
    .
  16. PMID 26844312
    . Evidence for benzodiazepine hypnotics, melatonin agonists in the general adult population, and most pharmacologic interventions in older adults was generally insufficient
  17. ^ a b c d e "Melatonin: Side Effects, Uses, Dosage (Kids/Adults)". Drugs.com. Retrieved 9 January 2019.
  18. ^ a b "Slenyto EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 31 May 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  19. ^ a b "Summary Safety Review – MELATONIN (N-acetyl-5-methoxytryptamine) – Review of the Safety of Melatonin in Children and Adolescents". Government of Canada. Health Canada. 10 December 2015. Retrieved 9 January 2019.
  20. ^ a b c "Melatonin- Oral". Government of Canada. Health Canada. 28 August 2018. Retrieved 9 January 2019.
  21. ^
    S2CID 235744969
    .
  22. ^ a b "Melatonin". www.drugbank.ca. Retrieved 29 January 2019.
  23. ^ "Australian Public Assessment Report for Melatonin" (PDF). Australian Government Department of Health and Ageing Therapeutic Goods Administration. January 2011. pp. 2, 4. Retrieved 9 January 2019. Monotherapy for the short term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.
  24. PMID 27500861
    .
  25. S2CID 3578916
    .
  26. ^ a b "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
  27. ^ a b "Melatonin - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
  28. ISBN 9781009000611
    .
  29. ^
    S2CID 71158456
    .
  30. ^
    PMID 12076414
    .
  31. ^
    PMID 25113164
    .
  32. PMID 23352028
    .
  33. PMID 28592453
    .
  34. PMID 26029267
    .
  35. ^
    PMID 33410930
    .
  36. PMID 33189083
    .
  37. S2CID 53101746
    .
  38. S2CID 88265944
    .
  39. ^ Soca R (28 February 2021). "Melatonin Product Availability". Keldik Sleep Circadian and Performance.
  40. PMID 29397794
    .
  41. ^ a b Brooks M (23 September 2022). "Experts Issue Health Warning About Giving Melatonin to Kids". Medscape.
  42. PMID 16423108
    .
  43. PMID 16473858
    .
  44. ^ "Melatonin: What You Need To Know". NCCIH. National Institutes of Health. Retrieved 2 July 2021.
  45. ^ Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature. 2014.
  46. PMID 31901302
    .
  47. PMID 25197811
    .
  48. ^ Bauer B. "Melatonin side effects: What are the risks?". Mayo Clinic. Retrieved 17 August 2011.
  49. PMID 11602091
    .
  50. PMID 18626968
    .
  51. PMID 16921343. Archived from the original
    on 2 November 2014. Retrieved 24 December 2013.
  52. S2CID 3442003
    .
  53. ISBN 978-0-87983-734-1
    .
  54. ^ "Melatonin – Special Subjects". Merck Manuals Professional Edition.
  55. PMID 16295212
    .
  56. ISBN 978-3-8055-9120-1
    .
  57. ^
    PMID 27314810
    .
  58. ^
    S2CID 10920415
    .
  59. ^ "Method for minimizing disturbances in circadian rhythms of bodily performance and function - Patent US-4665086-A - PubChem". pubchem.ncbi.nlm.nih.gov. Retrieved 16 April 2022.
  60. ^ US patent 5449683, Wurtman RJ, "Methods of inducing sleep using melatonin", issued 12 September 1995, assigned to Massachusetts Institute of Technology 
  61. S2CID 19011222
    . There is very little evidence in the short term for toxicity or undesirable effects in humans. The extensive promotion of the miraculous powers of melatonin in the recent past did a disservice to acceptance of its genuine benefits.
  62. PMID 11027748
    .
  63. ^
    S2CID 18050554
    .
  64. ^ "187 Fake Cancer 'Cures' Consumers Should Avoid". U.S. Food and Drug Administration. Archived from the original on 2 May 2017. Retrieved 20 May 2020.
  65. S2CID 31090576
    .
  66. ^ Hall H (15 December 2020). "Melatonin Melatonin supplements are increasingly popular, but the evidence is weak and mixed". Science-Based Medicine. Science Based Medicine. Retrieved 24 December 2020.
  67. PMID 27855744
    .
  68. ^ "Melatonin". Drugs.com. Retrieved 17 August 2011.
  69. ^ Loria K. "Does Melatonin Really Help You Sleep?". Consumer Reports. Retrieved 16 March 2019.
  70. ^ Louis CS (14 May 2011). "Dessert, Laid-Back and Legal". The New York Times.
  71. ^ Rodriguez RR (13 January 2010). "Warning Letter". Inspections, Compliance, Enforcement, and Criminal Investigations. U.S. Food and Drug Administration. Archived from the original on 12 January 2017.
  72. ^ "Bebida Beverage Company". U.S. Food and Drug Administration. 4 March 2015. Archived from the original on 1 June 2020. Retrieved 8 December 2017.
  73. PMID 29512136
    .
  74. ^
    S2CID 237485915
    .
  75. PMID 33319916
    .
  76. S2CID 28114683
    .
  77. S2CID 1196313
    . Retrieved 12 January 2018.
  78. PMID 26389506
    .
  79. S2CID 263492993
    .
  80. PMID 29397794
    .
  81. S2CID 38488628
    .
  82. PMID 10082913
    .
  83. PMID 9008723
    .
  84. PMID 27000311
    .
  85. PMID 9541644
    .
  86. S2CID 40005308
    .
  87. PMID 17641465
    .
  88. PMID 27513702
    .
  89. PMID 27000311
    .
  90. PMID 26967259
    .
  91. PMID 20082715
    .
  92. S2CID 16466238
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=Melatonin_as_a_medication_and_supplement&oldid=1216464596"